Stock listing

TWSE:6541 Tanvex Biopharma, Inc. (泰福-KY) 股價

Follow Tanvex Biopharma, Inc. into a list and get an email when it puts out news.

Share price · TWSE:6541

$30.45 TWD -0.45 (-1.5%)

Close on Oct 15, 2026

Ticker: TWSE:6541
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: TWSE
Currency: TWD

Latest news

Tanvex Biopharma: Represent subsidiary Tanvex BioPharma USA,Inc. to announce BLA resubmission for TX01(Neupogen Biosimilar)

Aug 15, 2022

Tanvex Biopharma: The Company has been required by TWSE to announce the financial data according to the regulations

Aug 4, 2022

Tanvex Biopharma: Represent subsidiary Tanvex BioPharma USA,Inc. to announce the result of FDA inspection for TX05(Herceptin Biosimilar)(supplementary)

Aug 1, 2022

Tanvex Biopharma: Represent subsidiary Tanvex BioPharma USA,Inc. to announce the result of FDA inspection for TX05(Herceptin Biosimilar)

Jul 31, 2022

Tanvex Biopharma: Represent subsidiary Tanvex BioPharma USA,Inc. to announce that TX01(Neupogen Biosimilar) got Drug Establishment Licence from Health Canada

Jul 24, 2022

Announcement of the Board of Directors' resolution on the appointment of corporate governance officer

Jul 15, 2022

Announcement of new appointment of the Company's Remuneration Committee.

Jul 15, 2022

The Announcement of Resolutions of 2022 Annual General Shareholders’ Meeting(Add any other proposals)

Jun 17, 2022

Announcement of the Resolution of Annual General Meeting to Approve of Lifting of Non-Competition Restrictions for Board Director.

Jun 17, 2022

Announcement of One Newly By-Elected Independent Director at 2022 General Shareholders' Meeting of Tanvex

Jun 17, 2022

All Tanvex Biopharma, Inc. news

Tanvex Biopharma, Inc. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 16 in all · newest Aug 15, 2022 · oldest 2022

Log in to ask 6ix AI your own questions about Tanvex Biopharma, Inc.